Increased plasma Interleukin-1β level is associated with memory deficits in type 2 diabetic patients with mild cognitive impairment. 2018

Sai Tian, and Rong Huang, and Jing Han, and Rongrong Cai, and Dan Guo, and Hongyan Lin, and Jiaqi Wang, and Shaohua Wang
Department of Endocrinology, Affiliated Zhongda Hospital of Southeast University, Nanjing, PR China; Medical School of Southeast University, Nanjing, PR China.

Type 2 diabetes mellitus (T2DM) and mild cognitive impairment (MCI) are both chronic inflammatory diseases. We aimed to investigate the association of plasma Interleukin-1β (IL-1β) levels with the risk of MCI in T2DM patients. We divided recruited T2DM patients into two groups, MCI group and healthy-cognition controls, according to Montreal Cognitive Assessment (MoCA) scores. Demographic characteristics, clinical parameters and neuropsychological tests were examined. We recruited 202 T2DM patients in this study, including 94 MCI and 108 healthy-cognition controls. T2DM patients with MCI exhibited increased plasma IL-1β and decreased amyloid-β 42 (Aβ42) levels compared to the controls (all p < 0.05). After adjusting fasting blood glucose (FBG), glycosylated hemoglobin (HbA1c), homeostasis model assessment of insulin resistance (HOMA-IR) and Aβ42, plasma IL-1β levels were negatively correlated with MoCA and AVLT delayed recall scores, which represented memory function. Multivariable logistic regression model showed that high plasma IL-1β level and low plasma Aβ42 level were correlated with increased risk for MCI in T2DM patients. Increased plasma IL-1β level was significantly associated with MCI in T2DM patients, especially memory deficits. Our findings will provide additional insights into the inflammation pathogenesis of cognitive impairments in T2DM.

UI MeSH Term Description Entries
D008297 Male Males
D008569 Memory Disorders Disturbances in registering an impression, in the retention of an acquired impression, or in the recall of an impression. Memory impairments are associated with DEMENTIA; CRANIOCEREBRAL TRAUMA; ENCEPHALITIS; ALCOHOLISM (see also ALCOHOL AMNESTIC DISORDER); SCHIZOPHRENIA; and other conditions. Memory Loss,Age-Related Memory Disorders,Memory Deficits,Memory Disorder, Semantic,Memory Disorder, Spatial,Memory Disorders, Age-Related,Retention Disorders, Cognitive,Semantic Memory Disorder,Spatial Memory Disorder,Age Related Memory Disorders,Age-Related Memory Disorder,Cognitive Retention Disorder,Cognitive Retention Disorders,Deficit, Memory,Deficits, Memory,Memory Deficit,Memory Disorder,Memory Disorder, Age-Related,Memory Disorders, Age Related,Memory Disorders, Semantic,Memory Disorders, Spatial,Memory Losses,Retention Disorder, Cognitive,Semantic Memory Disorders,Spatial Memory Disorders
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009483 Neuropsychological Tests Tests designed to assess neurological function associated with certain behaviors. They are used in diagnosing brain dysfunction or damage and central nervous system disorders or injury. Aphasia Tests,Cognitive Test,Cognitive Testing,Cognitive Tests,Memory for Designs Test,Neuropsychological Testing,AX-CPT,Behavioral Assessment of Dysexecutive Syndrome,CANTAB,Cambridge Neuropsychological Test Automated Battery,Clock Test,Cognitive Function Scanner,Continuous Performance Task,Controlled Oral Word Association Test,Delis-Kaplan Executive Function System,Developmental Neuropsychological Assessment,Hooper Visual Organization Test,NEPSY,Neuropsychologic Tests,Neuropsychological Test,Paced Auditory Serial Addition Test,Repeatable Battery for the Assessment of Neuropsychological Status,Rey-Osterrieth Complex Figure,Symbol Digit Modalities Test,Test of Everyday Attention,Test, Neuropsychological,Tests, Neuropsychological,Tower of London Test,Neuropsychologic Test,Test, Cognitive,Testing, Cognitive,Testing, Neuropsychological,Tests, Cognitive
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D003071 Cognition Intellectual or mental process whereby an organism obtains knowledge. Cognitive Function,Cognitions,Cognitive Functions,Function, Cognitive,Functions, Cognitive
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Sai Tian, and Rong Huang, and Jing Han, and Rongrong Cai, and Dan Guo, and Hongyan Lin, and Jiaqi Wang, and Shaohua Wang
January 2017, Current Alzheimer research,
Sai Tian, and Rong Huang, and Jing Han, and Rongrong Cai, and Dan Guo, and Hongyan Lin, and Jiaqi Wang, and Shaohua Wang
January 2022, Diabetes, metabolic syndrome and obesity : targets and therapy,
Sai Tian, and Rong Huang, and Jing Han, and Rongrong Cai, and Dan Guo, and Hongyan Lin, and Jiaqi Wang, and Shaohua Wang
June 2020, Neurobiology of disease,
Sai Tian, and Rong Huang, and Jing Han, and Rongrong Cai, and Dan Guo, and Hongyan Lin, and Jiaqi Wang, and Shaohua Wang
September 2012, Neuropsychology, development, and cognition. Section B, Aging, neuropsychology and cognition,
Sai Tian, and Rong Huang, and Jing Han, and Rongrong Cai, and Dan Guo, and Hongyan Lin, and Jiaqi Wang, and Shaohua Wang
January 2021, Frontiers in aging neuroscience,
Sai Tian, and Rong Huang, and Jing Han, and Rongrong Cai, and Dan Guo, and Hongyan Lin, and Jiaqi Wang, and Shaohua Wang
May 2022, BMC endocrine disorders,
Sai Tian, and Rong Huang, and Jing Han, and Rongrong Cai, and Dan Guo, and Hongyan Lin, and Jiaqi Wang, and Shaohua Wang
January 2020, Diabetes, metabolic syndrome and obesity : targets and therapy,
Sai Tian, and Rong Huang, and Jing Han, and Rongrong Cai, and Dan Guo, and Hongyan Lin, and Jiaqi Wang, and Shaohua Wang
December 2019, Alzheimer's & dementia (Amsterdam, Netherlands),
Sai Tian, and Rong Huang, and Jing Han, and Rongrong Cai, and Dan Guo, and Hongyan Lin, and Jiaqi Wang, and Shaohua Wang
March 2016, The journals of gerontology. Series B, Psychological sciences and social sciences,
Sai Tian, and Rong Huang, and Jing Han, and Rongrong Cai, and Dan Guo, and Hongyan Lin, and Jiaqi Wang, and Shaohua Wang
January 2006, Dementia and geriatric cognitive disorders,
Copied contents to your clipboard!